Young adults bear heavy type 2 diabetes burden; probiotics cut bone loss after menopause
By Sara Freeman
Younger people with type 2 diabetes need a more focused treatment strategy, irrespective of cardiometabolic risk.
You can take the MDedge Podcasts survey by clicking here.
Twelve months of the probiotics treatment prevented bone mineral density loss in the lumbar spine when compared with placebo.
A positive dose-response relationship exists between the number of insomnia symptoms and the risk of cardiocerebral vascular disease.
The largest-ever meta-analysis shows a 43% relative risk reduction in HCC.
Data highlight an increase in prevalence at diagnosis, but certain factors may help identify those most at risk.